News

The proposed revisions represent “a formal, federal acknowledgment that medical marijuana is no longer in the same legal category it once occupied.” By Dan Russell and Will Hall, Jones Walker LLP In recent years approximately 4 million Americans lost their right to buy, possess or use a firearm. An overwhelming percentage of those people have no idea that the same federal law that led to Hunter Biden’s conviction also applied to them. In the Venn diagram of life in the United States, the overlap of firearm ownership and medical marijuana patients is simply not allowed. The future, however, is . . .

People who use marijuana aren’t more or less likely to be physically active compared to non-users-but they do tend to favor light or moderate exercise, suggesting that “cannabis may influence the subjective experience” such as “enjoyment,” according to a new study that undermines the stereotype about lazy stoners. Students with the University of Alabama at Birmingham’s Heersink School of Medicine conducted the study, which involved a cross-sectional analysis of survey data. One of the key takeaways departs from the myth about couch-locked cannabis consumers, finding that marijuana use “was . . .

President Donald Trump has seen a massive swing in support for his administration’s marijuana policy actions from consumers since moving to federally reschedule medical cannabis-with nearly three out of four now having a favorable view-according to a new survey. The latest quarterly presidential approval tracking poll from NuggMD and Marijuana Moment found that 73 percent of marijuana consumers now either “approve” or “strongly approve” of the Trump administration’s cannabis actions. Just 7 percent say they’re opposed, while 20 percent have no opinion. Do you approve or disapprove of the . . .

The Minnesota cannabis program is online and rolling out slowly. Too slowly, in this writer’s humble opinion. That said, a handful of tribal dispensaries have been operating since 2023, and adult use sales at non-tribal shops began in September 2025. To the good, sales are ticking up each month. In April, the Office of Cannabis Management (OCM) tracker showed $15M in collected revenue from adult-use sales, and $10M in collected revenue from medical sales. This steady improvement, along with Minnesota’s robust population, regulatory philosophy, and the income tax relief that may come with . . .

For hemp farmers, few guests are less welcome than the corn earworm. Named after its main source of food, the corn earworm is also a big fan of the hemp plant – particularly when their favorite meal is out of season – feasting on the flowers and destroying up to 60% of the plant’s yield. “They are known to eat the flower portion, which is the marketable part of the plant most of the time,” says Freweyni Abrha, a Ph.D. student at the University of Maryland, Eastern Shores. Abrha has a Bachelor of Science in plant science, a master’s degree in plant pathology and this past year was one of the . . .

Curaleaf Holdings Inc (TSE: CURA) (OTCMKTS: CURLF) dominated the 2026 Business of Cannabis Awards this month by securing multiple honours, including Cannabis Clinic of the Year for its UK operations, Cannabis Team of the Year for Curaleaf Laboratories and European Company of the Year for the second time. Curaleaf outperformed strong nominees in these categories. For the clinic award, competitors included British clinic MAMEDICA, Cantourage Group SE (ETR: HIGH) (FRA: HIGH) and Medicann. In the team category, Tilray Brands Inc (TSE: TLRY) (NASDAQ: TLRY) (FRA: 2HQ) and Cantourage stood out among . . .

“Generally, the changes needed to happen so that we could bring the focus back to the intention of the program.” By Rebecca Rivas, Missouri Independent Lesley Turek is planning for a busy June traveling the state to educate people about the final lottery for 77 microbusiness marijuana licenses. Turek, the chief equity officer for the Missouri Division of Cannabis Regulation, will hold education sessions in Kansas City, Jefferson City and St. Louis, along with five webinars to outline application requirements and answer questions. The application window will open sometime in midsummer, she . . .

While news of rescheduling has dominated the U.S. cannabis news cycle, discerning eyes are also looking overseas. All around the world, the industry is emerging-some faster than others. According to a new report, Europe is quickly becoming a behemoth in the global cannabis market, a development that could have a far-reaching impact. RELATED: DEA opens cannabis registration, but key questions remain The report, a joint effort between the Global Cannabis Network Collective (GCNC) and Whitney Economics, declares the European Union (EU) is now the second-largest cannabis total addressable market . . .

Virginia’s governor may have vetoed bills to legalize recreational marijuana sales last week, but that doesn’t mean it can’t still happen this year. Top lawmakers are openly discussing the possibility of including provisions to enact the cannabis reform in still-outstanding budget legislation that they are due to pass by July 1. Senate Majority Leader Scott Surovell (D), for example, said the issue is not “dead” for 2026 yet. “It is possible for us, however, to put policy like that into the budget and adopt it in the budget and then put that on the governor’s desk,” Surovell, who also chairs . . .

The National Organization for the Reform of Marijuana Laws (NORML) is seeking to participate in the Drug Enforcement Administration’s upcoming administrative hearing regarding the broad rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). The hearing, set for June 29, will consider the 2023 recommendation by the Department of Health and Human Services to reclassify cannabis broadly under the CSA and is separate from the recent decision by the federal government to move medical cannabis from Schedule I to Schedule III. NORML is seeking . . .

The United Food and Commercial Workers International (UFCW) union is joining Democratic lawmakers in their request that President Donald Trump (R) pardon everyone in prison for all non-violent cannabis crimes. Last week, 28 Democratic lawmakers, along with independent Sen. Bernie Sanders (VT), sent a letter to Trump and his pardon czar Alice Marie Johnson seeking the relief, noting that data from the U.S. Sentencing Commission estimates that there are about 3,000 people federally incarcerated for cannabis trafficking offenses, and some hundreds or thousands more serving . . .

A former notary for Nebraska petitions to legalize medical cannabis in 2024 is appealing his criminal convictions related to improper notarizations, the Nebraska Examiner reports. Jacy C. Todd was found guilty in February of 23 counts of “official misconduct” – each a Class II misdemeanor – and one count of making a false statement under oath. Todd was sentenced to a $2,866.44 fine, but no jail time. Todd and his attorney, Mark Porto, on May 11 filed a notice of intent to appeal the convictions and sentence. Todd was found to have improperly notarized petitions related to the campaign . . .

Litigious retailer Catalyst has filed another lawsuit against the California Department of Tax and Fee Administration (CDTFA) on top of the one it is already waging against the agency. The ongoing lawsuit, originally filed in 2023 by a Catalyst affiliate, involves an interpretation of how the state excise tax should be applied. Catalyst argues it should only apply to cannabis and not cannabis accessories as long as they appear separately on the receipt. In . . . Log in or become a WeedWeek Member to read this article. The post SCOOP: Catalyst sues Calif. tax agency, again appeared first on . . .

Three Republican state attorneys general have filed a lawsuit challenging the federal cannabis rescheduling action announced by President Donald Trump’s Department of Justice last month. The filing from the attorneys general of Indiana, Nebraska and Louisiana claims that they will “show that this agency action fails to comport with the requirements” of federal law, “was improperly promulgated and was otherwise procedurally improper,” “exceeds or is inconsistent with pertinent authority” and “ultimately, that this agency action is arbitrary, capricious, an abuse of discretion, and not in . . .

As the U.S. cannabis industry matures, one phrase is everywhere from dispensary menus to online listings: top shelf. But what does “top-shelf cannabis” mean? For experienced consumers, it’s more than a label. It’s a combination of genetics, cultivation, processing, and overall experience. And as the market becomes more competitive, understanding what defines true quality is [ . . . ] Source: Top-Shelf Cannabis: What Defines Quality in Today’s Market from Heady NJ

CBD products have become a popular option for people seeking wellness support, stress management, recovery assistance, and better sleep who don’t want to get high via THC. THC is what gets you high in weed. This is a difficult issue for people who undergo workplace drug testing, compete in sports, or simply prefer to avoid [ . . . ] Source: How to Choose CBD Products with Lower THC from Heady NJ

When you have allegations of drug crimes against you, it is necessary to understand the legal system and what you need to do. Getting arrested for a drug crime can make you feel like your entire life seems to have changed. The hours and days following an arrest for possession, distribution, or a more serious [ . . . ] Source: What Should You Do If You’re Facing Drug Crime Charges? from Heady NJ

Bipartisan congressional lawmakers say they’re working to codify into law an executive order President Donald Trump issued to streamline research and access into psychedelic medicine. Reps. Lou Correa (D-CA) and Jack Bergman (R-MI)-co-chairs of the Congressional Psychedelics Advancing Therapies (PATH) Caucus-both recently spoke about the need to enact into law provisions to protect the intent of the executive action to ensure ongoing support for psychedelics research for military veterans and people with certain mental health conditions even under future president’s. During an interview with . . .

What You Need to Know to Exercise Your Rights Under the New Cannabis Laws On April 28, 2026, federal cannabis policy changed.

When it comes to Europe’s emerging legal cannabis industry, Germany continues to stand alone as the undisputed continental leader. Germany launched legal medical cannabis sales through the nation’s pharmacies in 2017, and since that time, the nation’s legal market has increased exponentially in size and market value. One of the best ways to help quantify how large Germany’s legal medical cannabis industry has become is to look at medical cannabis import totals. In addition to domestic medical cannabis production, Germany’s legal cannabis industry imports a considerable number of products from . . .

“I’m proud to continue contributing to the growth and success of Rhode Island and its cannabis industry.” By Christopher Shea, Rhode Island Currant Gov. Dan McKee (D) has nominated the state’s top cannabis administrator to chair the panel that oversees Rhode Island’s cannabis industry, which has now been without a leader for over seven months. McKee on Tuesday nominated Michelle Reddish to the Cannabis Control Commission seat left vacant last October after then-Chairperson Kim Ahern resigned to pursue a run for state attorney general. Reddish has served as administrator of the Rhode Island . . .

Hemp farmers and industry advocates will have a challenging time stopping the planned federal recriminalization of hemp THC products that’s scheduled to take effect later this year, Sen. Ted Cruz (R-TX) says. But, he added, it will be easier to pass legislation on the issue next year when Sen. Mitch McConnell (R-KY), who led the push for the new ban, will likely be replaced by another Republican senator who supports keeping the crop’s derivates legal. “I think the way Congress handled it and treated the hemp industry was really unfair,” Cruz said during a Zoom meeting with members of the . . .

The New Jersey Economic Development Authority (NJEDA) announced Tuesday that the agency still has approximately $5 million in funding available for licensed cannabis businesses via the Cannabis Business Development (CBD) Grant Program. The funding is available in the form of $75,000 reimbursements to help eligible cannabis manufacturers, cultivators, retailers, and testing laboratories. The one-time refund on business expenses is meant to help “alleviate” the costs of maintaining compliance with state and local laws for early-stage cannabis companies. NJEDA said it has already disbursed $5 . . .

Illinois state lawmakers could pass major cannabis and hemp policy changes during the last few days of this year’s legislative session, WAND reports. The proposals, HB 5784 and SB 20, seek to regulate hemp-derived CBD products and establish the Illinois medical and adult-use cannabis industries. Co-sponsored in the Senate by Sen. Majority Leader Kimberly Lightford (D), the legislation would create a regulatory framework for non-intoxicating, hemp-derived CBD products ahead of the federal pivot coming this November on hemp-derived THC. The legislation also seeks to enact multiple cannabis . . .

A recent poll showed that most Virginia voters disagree with Gov. Abigail Spanberger’s (D) veto of legislation to legalize recreational marijuana sales-but the disappointment in the move extends to members of her own family, the governor says. “I know a lot of people are not pleased with that veto,” she said in an interview with actor and content creator Tevin Davis that was posted on Monday. “Friends and family are displeased as well.” “I do think it’s an obligation to get it right, and I can’t overstate the fact that I was really dug in on the details on this bill-and it’s all about making . . .